Drugs.com: Escitalopram reduces symptoms of anxiety in teens
Outlet covers UC research that points to a possible new treatment for adolescent anxiety
For adolescents with generalized anxiety disorder, UC research has shown that the medication escitalopram could reduce symptoms. The study was published online Aug. 25 in The Journal of Clinical Psychiatry.
Jeffrey Strawn, MD, associate professor and anxiety expert in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati, and colleagues treated adolescents with anxiety disorder with escitalopram or a placebo for eight weeks to see if improvement occurred.
"For clinicians treating anxious adolescents, this study provides preliminary answers to important questions about the effectiveness of this treatment," Strawn says.
Read the full Drugs.com story.
Psych Central also reported on this research.
Read the full UC News release.
Featured photo courtesy of Unsplash.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.